Cargando…
Cardiotoxicity of Novel Targeted Hematological Therapies
Chemotherapy-related cardiac dysfunction, also known as cardiotoxicity, is a group of drug-related adverse events negatively affecting myocardial structure and functions in patients who received chemotherapy for cancer treatment. Clinical manifestations can vary from life-threatening arrythmias to c...
Autores principales: | Giudice, Valentina, Vecchione, Carmine, Selleri, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763613/ https://www.ncbi.nlm.nih.gov/pubmed/33322351 http://dx.doi.org/10.3390/life10120344 |
Ejemplares similares
-
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
por: Giudice, Valentina, et al.
Publicado: (2020) -
Clonal Non-Malignant Hematological Disorders: Unraveling Molecular Pathogenic Mechanisms to Develop Novel Targeted Therapeutics
por: Risitano, Antonio M., et al.
Publicado: (2014) -
Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance
por: De Novellis, Danilo, et al.
Publicado: (2022) -
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature
por: Giudice, Valentina, et al.
Publicado: (2021) -
Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers
por: Napolitano, Filomena, et al.
Publicado: (2023)